Advertisement
Canada markets close in 1 hour 38 minutes

  • S&P/TSX

    22,043.64
    +171.68 (+0.78%)
     

  • S&P 500

    5,075.78
    +65.18 (+1.30%)
     

  • DOW

    38,535.75
    +295.77 (+0.77%)
     

  • CAD/USD

    0.7321
    +0.0020 (+0.27%)
     

  • CRUDE OIL

    83.38
    +1.48 (+1.81%)
     

  • Bitcoin CAD

    91,299.34
    +315.01 (+0.35%)
     

  • CMC Crypto 200

    1,437.69
    +22.93 (+1.62%)
     

  • GOLD FUTURES

    2,342.10
    -4.30 (-0.18%)
     

  • RUSSELL 2000

    2,008.72
    +41.25 (+2.10%)
     

  • 10-Yr Bond

    4.5860
    -0.0370 (-0.80%)
     

  • NASDAQ

    15,722.94
    +271.63 (+1.76%)
     

  • VOLATILITY

    15.93
    -1.01 (-5.97%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Amplitude Healthcare Acquisition Corporation (Nasdaq – AMHC)

ACCESSWIRE
·2 min read

BALA CYNWYD, PA / ACCESSWIRE / May 6, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Amplitude Healthcare Acquisition Corporation ("Amplitude Healthcare" or the "Company") (Nasdaq:AMHC) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which Amplitude Healthcare, a special purpose acquisition company, will combine with Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and result in Jasper Therapeutics becoming a publicly-listed company. Under the terms of the agreement, Amplitude Healthcare shareholders will retain ownership of only 20.4% of the combined company.

The investigation concerns whether the Amplitude Healthcare Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of ownership interest in the combined company.

If you own shares of Amplitude Healthcare stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/amplitude-healthcare-acquisition-corporation-nasdaq-amhc/, or call toll free 855-576-4847.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

ADVERTISEMENT

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/645257/SHAREHOLDER-NOTICE-Brodsky-Smith-LLC-Announces-an-Investigation-of-Amplitude-Healthcare-Acquisition-Corporation-Nasdaq-AMHC